Pharmaceutical GLP-1 receptor agonists are licensed for type 2 diabetes and specific obesity indications according to NICE guidance, requiring GP consultation and monitoring
They work by mimicking a naturally occurring hormone that helps regulate: Blood sugar levels Appetite Digestion Food intake Researchers later discovered that these medications could also produce substantial weight loss
Song QH, Xu RM, Zhang QH, Shen GQ, Ma M, Zhao XP, Guo YH, Wang Y
Mounjaro may also slow the emptying of the stomach, leading to feelings of fullness
So, whether you're taking Wegovy, Ozempic, or Rybelsus, the medication stays in your body for quite a while after you stop taking it. This extended presence in the body is related to semaglutide's half-life, which is about 1 week
Lillys triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial. PR Newswire, May 21, 2026